Show simple item record

dc.contributor.authorMassey, E
dc.contributor.authorHarding, K
dc.contributor.authorKahan, B C
dc.contributor.authorLlewelyn, C
dc.contributor.authorWynn, R
dc.contributor.authorMoppett, J
dc.contributor.authorRobinson, S P
dc.contributor.authorGreen, A
dc.contributor.authorLucas, G
dc.contributor.authorSadani, D
dc.contributor.authorLiakopoulou, Effie F
dc.contributor.authorBolton-Maggs, P
dc.contributor.authorMarks, D I
dc.contributor.authorStanworth, S
dc.date.accessioned2012-11-09T16:56:57Z
dc.date.available2012-11-09T16:56:57Z
dc.date.issued2012-08
dc.identifier.citationThe granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. 2012, 22 (4):277-84 Transfus Meden_GB
dc.identifier.issn1365-3148
dc.identifier.pmid22591484
dc.identifier.doi10.1111/j.1365-3148.2012.01152.x
dc.identifier.urihttp://hdl.handle.net/10541/251608
dc.description.abstractTo evaluate the safety of transfusing pooled, whole blood-derived granulocytes in additive solution and plasma (GASP) in 30 recipients.
dc.language.isoenen
dc.rightsArchived with thanks to Transfusion medicine (Oxford, England)en_GB
dc.titleThe granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma.en
dc.typeArticleen
dc.contributor.departmentNHS Blood and Transplant, North Bristol Park, Northway Filton, Bristol BS34 7QH, UK.en_GB
dc.identifier.journalTransfusion Medicineen_GB
html.description.abstractTo evaluate the safety of transfusing pooled, whole blood-derived granulocytes in additive solution and plasma (GASP) in 30 recipients.


This item appears in the following Collection(s)

Show simple item record